The Board of Directors of the i2b2 tranSMART are listed below with links to their Bio’s and social media.
Lawrence J. Henderson Professor of Pediatrics Isaac Kohane is the new head of the new Department of Biomedical Informatics at Harvard Medical School. He is pictured in Countway Library in the rare books collection, the original big data, at HMS. Stephanie Mitchell/Harvard Staff Photographer
Professor & Chair, Department of Biomedical Informatics at Harvard Medical School
Dr. Kohane is driven by the vision of what biomedical researchers could do to find new cures, provide new diagnoses and deliver the best care available if data could be converted more rapidly to knowledge and knowledge to practice. Dr. Kohane created DBMI at Harvard and was instrumental in the creation and support of the i2b2 platform and is the Foundation Board Chair.
Board Term: 2017-2021.
Gil Omenn MD PhDProfessor, U Michigan
Professor of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics, & Public Health, University of Michigan, Ann Arbor. Dr. Omenn’s research focuses on cancer proteogenomics, splice isoforms, and prediction of functions of unannotated proteins. He is a leader of the global Human Proteome Project. He is a member of the National Academy of Medicine and past president of the AAAS.
Griffin Weber MD PhDAssociate Professor, Harvard Medical School
Department of Medicine, Interdisciplinary Medicine and Biotechnology (IMBIO), Beth Israel Deaconess Medical Center. Previously, Dr Weber was Chief Technology Officer at Harvard Medical School and Director of the Biomedical Research Informatics Core (BRIC) Beth Israel Deaconess Medical Center. Dr Weber was the original author of the i2b2 WebClient.
Shawn Murphy MD PhDChief Research Information Officer, Partners HealthCare
Dr Murphy is also Professor of Neurology and Biomedical Informatics at Harvard Medical School. He has developed the initial Research Patient Data Registry (RPDR) for Partners HealthCare, a large data warehouse with 7 million patients and 3 billion rows.
Dr. Murphy is the chief architect of the NIH Sponsored Informatics for Integrating Biology and the Bedside (i2b2).
David DimondChief Innovation Officer, Dell Technologies
Dave’s charter is to establish alliance partner collaborations to drive joint engineering, develop and commercialize of data intensive cloud-based platforms for healthcare. Dave was strategic advisor to healthcare startups and investment banks, co-founding WhatNext, social media for sharing patient experience with the American Cancer Society and philanthropic organizations.
Susanne E. Churchill PhDExecutive Director, DBMI, Harvard Medical School
Dr. Churchill is executive director of DBMI, and the Big Data to Knowledge (BD2K) Center of Excellence. Dr. Churchill also serves as the executive director of the N-GRID (neuropsychiatric genome-scale and RDoC-Individualized domains). She also serves at the Center of Excellence in Genome Science and program director for the Summer Institute in Biomedical Informatics (SIBMI).
Paul Avillach MD PhDAssistant Professor, Harvard Medical School
Avillach focuses on the novel methods and techniques for the integration of multiple heterogeneous clinic cohorts, electronic health records, and multiple types of genomics data to encompass biological observations. He is PI and Co-PI on several projects including the BD2K PIC-SURE Center of Excellence, the Global Rare Diseases Registry project, the PCORI ARCH project, and the PCORI Phelan-Mcdermid Syndrome project.
Andreas Kremer PhDCo-Founder and CEO, ITTM
Over 20 years of experience in Pharma, Clinical Research and Diagnostics always focussing on data quality and interoperability aspects. ITTM (Information Technology for Translational Medicine) provides data integration and knowledge management solutions and services, especially data curation and harmonization incl. hosting of knowledge platforms and process optimization solutions.
Ulrich Sax PhDProfessor, U Gottingen
Vice head of the Department of Medical Informatics, University Medical Center. Long term experience in design, operation and validation of IT infrastructure for health care and translational research. He heads the Interoperability working group of the German Medical Informatics Initiative. Dr. Sax is active in the Technology and Method Platform for Networked Medical Research, including spokesman for the quality management working group.
Ken Mandl MD MPHProfessor, Boston Children's Hospital
Dr Mandl is Director, Computational Health Informatics Program at Boston Children’s Hospital and the Donald A.B. Lindberg Professor of Pediatrics & Biomedical Informatics at Harvard Medical School. Dr Mandl works at the intersection of population and individual health, where Mandl has been a pioneer of the first personally controlled health record systems, and co-developed SMART, a widely used technology to enable a health app to access digital health data and run anywhere in the health care system.
Becky SteckDirector of Software Solutions, Nephrology, U Michigan
Ms. Steck is the Director of Software Solutions for the U of Michigan’s nephrology division. She is focused on identifying, developing, and integrating software solutions to enable research collaborations and ultimately improve patient outcomes.
She is passionate about user-centered design, process improvement, and pragmatism. She leads the Data Visualization Center for the Kidney Precision Medicine Project.
Qi Li MD MBAPhyscian Executive, InterSystems
Innovator, entrepreneur, product management, research, and global business development. Leading innovation initiatives in product, technology, and market segment including life science, research, precision medicine, real world evidence, and AI. He led product development, strategy, and UK/China healthcare IT market entry. At Partners HealthCare, led the development of LMR, enterprise EMR solution, and grants. Passionate about translational research and disruptive technology.
Deven Atnoor PhDGlobal Industry Specialist, Amazon
Building data integration platforms, applications and advanced analytics to solve problems in life-sciences and healthcare. Progressive experience in product development and management with focus on emerging technologies and datasets – Clinical, Financial and Omics. Creating and leading innovative solutions focused on answering burning questions in Drug discovery, disease diagnosis and Treatment, population and outcomes research.